Eye to Brain Connection
NCT05215782 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 65
Last updated 2023-03-24
Summary
This is a non-randomized, non-treatment, observational study designed to discover correlations between retinal imaging and amyloid PET imaging. Subjects will be recruited to the clinical cohort from referring physicians. Subjects may be participants from existing studies and clinical practices
Conditions
- Alzheimer Disease
Sponsors & Collaborators
-
Ezy Medical Research
collaborator UNKNOWN -
Optina Diagnostics Inc.
lead INDUSTRY
Eligibility
- Min Age
- 50 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-03-14
- Primary Completion
- 2023-03-16
- Completion
- 2023-03-16
Countries
- United States
Study Locations
More Related Trials
-
Multimodal Ocular Imaging in Neurodegeneration
NCT03699644 ·Status: COMPLETED
-
Amyloid Plaque and Tangle Imaging in Alzheimer's Disease and Down Syndrome
NCT00965835 ·Status: UNKNOWN
-
Genomic Profiling of Mitochondrial Disease - Imaging Analysis for Precise Mitochondrial Medicine
NCT05012358 ·Status: COMPLETED
-
Amyloid PET Imaging in the Baltimore Longitudinal Study of Aging
NCT07099053 ·Status: RECRUITING
-
Serotonin and Amyloidopathy
NCT02895932 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of the PET Imaging Agent [18F]NAV4694 in Subjects With Probable Alzheimer's Disease
NCT01680588 ·Status: UNKNOWN ·Phase: PHASE2
-
PET Imaging of Brain Amyloid Using [11C]MeS-IMPY
NCT00407576 ·Status: COMPLETED ·Phase: PHASE1
-
PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
NCT04396873 ·Status: RECRUITING ·Phase: PHASE1
-
Investigation of AlzHeimer's Predictors in Subjective Memory Complainers - Extension Study
NCT05806697 ·Status: RECRUITING ·Phase: NA
-
Relationship Between Down Syndrome (DS) and Alzheimer's Disease (AD)
NCT02759887 ·Status: COMPLETED ·Phase: NA
-
Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
NCT06584357 ·Status: RECRUITING
-
Multimodal Retinal Imaging in the Detection and Follow-up of Alzheimer's Disease
NCT03466177 ·Status: RECRUITING
-
Diagnostic Accuracy of Optimized Diffusion-Weighted Imaging for Detecting Anterior Ischemic Optic Neuropathy
NCT04451265 ·Status: RECRUITING
-
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
NCT01886820 ·Status: UNKNOWN ·Phase: PHASE3
-
Brain Imaging in Elderly People and Individuals With Alzheimer's Disease
NCT00001917 ·Status: COMPLETED
-
Selective PET Imaging of Astrocytes and Microglia in Alzheimer's Disease
NCT05582200 ·Status: RECRUITING
-
Imaging of Brain Amyloid Plaques in the Aging Population
NCT00950430 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Molecular and Structural Imaging in Alzheimer's Disease: A Longitudinal Study
NCT02740634 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Safety and Efficacy of Positron Emission Tomography (PET) Imaging With MNI-558
NCT01217021 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Neuroimaging and Neurovision Rehabilitation of Oculomotor Dysfunction in Mild Traumatic Brain Injury
NCT02771106 ·Status: COMPLETED
-
Optimization and Harmonization of Advanced MRI Sequences
NCT06217237 ·Status: COMPLETED
-
FluoroAv45 Imaging Research-in Alzheimer's Disease
NCT01325259 ·Status: COMPLETED ·Phase: PHASE2
-
Blood-Brain-Barrier Opening Using Focused Ultrasound With IV Contrast Agents in Patients With Early Alzheimer's Disease
NCT02986932 ·Status: COMPLETED ·Phase: NA
-
MRI of Alzheimer's Disease Imaging Amyloid Plaques in Persons With and Without Memory Problems
NCT00413621 ·Status: COMPLETED
-
Beta-Amyloid Imaging With [18F]NAV4694 PET in Predicting Progression to AD in Subjects MCI
NCT01812213 ·Status: TERMINATED ·Phase: PHASE2